From June 7, 2022 to July 6, 2022, the company has repurchased 39,777 shares, representing 0.66% for KRW 4,574.17 million. With this, the company has completed the repurchase of 39,777 shares, representing 0.66% for KRW 4,574.17 million under the buyback announced on June 7, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
159,500 KRW | +4.32% | +5.21% | -33.82% |
May. 16 | Medy-Tox Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Mar. 21 | Medy-Tox Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-33.82% | 781M | |
+6.96% | 101B | |
+8.29% | 42.63B | |
-11.09% | 33.5B | |
+82.32% | 29.77B | |
-11.82% | 16.14B | |
+1.39% | 14.31B | |
-12.13% | 11.55B | |
+176.65% | 10.53B | |
+6.74% | 9.2B |
- Stock Market
- Equities
- A086900 Stock
- News Medy-Tox Inc.
- Tranche Update on Medy-Tox Inc.'s Equity Buyback Plan announced on June 7, 2022.